Cargando…
Potential crosstalk between cofilin-1 and EGFR pathways in cisplatin resistance of non-small-cell lung cancer
Current challenge in oncology is to establish the concept of personalized medicine in clinical practice. In this context, non-small-cell lung cancer (NSCLC) presents clinical, histological and molecular heterogeneity, being one of the most genomically diverse of all cancers. Recent advances added Ep...
Autores principales: | Müller, Carolina Beatriz, De Bastiani, Marco Antônio, Becker, Matheus, França, Fernanda Stapenhorst, Branco, Mariane Araujo, Castro, Mauro Antônio Alves, Klamt, Fábio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414134/ https://www.ncbi.nlm.nih.gov/pubmed/25784483 |
Ejemplares similares
-
Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin–EGFR crosstalk
por: Li, Dandan, et al.
Publicado: (2018) -
Integrated transcriptomics reveals master regulators of lung adenocarcinoma and novel repositioning of drug candidates
por: De Bastiani, Marco Antônio, et al.
Publicado: (2019) -
Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
por: Wen, Miaomiao, et al.
Publicado: (2018) -
Crosstalk between COVID-19 and prostate cancer
por: Bahmad, Hisham F., et al.
Publicado: (2020) -
A comparative study of COVID-19 transcriptional signatures between clinical samples and preclinical cell models in the search for disease master regulators and drug repositioning candidates
por: Chapola, Henrique, et al.
Publicado: (2023)